Astrazeneca ADR Aktie
Deine Einschätzung
Astrazeneca ADR Aktie
Was spricht für und gegen Astrazeneca ADR in den nächsten Jahren?
Pro
Kontra
Rendite von Astrazeneca ADR im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Astrazeneca ADR | 0,00 % | -1,39 % | 10,08 % | 2,16 % | 15,45 % | 56,04 % | - |
GSK plc ADR | -0,48 % | 0,49 % | 9,52 % | 21,76 % | 23,21 % | 2,86 % | -5,80 % |
Bayer AG ADR | - | 4,44 % | 10,16 % | -46,59 % | -18,02 % | -50,00 % | -50,70 % |
Roche Holding AG ADR | 1,12 % | 5,19 % | 5,65 % | -16,96 % | -7,08 % | -13,37 % | - |
Kommentare
https://www.nasdaq.com/articles/is-it-too-late-to-buy-the-most-promising-pipeline-in-the-pharma-industry-2021-05-28
News
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock. But I see an investment that's full of uncertainty and risk.
The company continually runs into
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
AstraZeneca Plc (NASDAQ: AZN)Q1 2024 Earnings CallApr 25, 2024, 6:45 a.m. ET
Operator
Source Fool.com
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.
Weight-loss drugs are hot. Just look at the recent performances of Eli Lilly (NYSE: LLY), which won U.S. approval in November for Zepbound, and Novo Nordisk (NYSE: NVO), which markets Ozempic and